Problem

Aegis addresses the revenue leakage and administrative burden created by denied health-insurance claims. Healthcare providers reportedly lose more than $260 billion annually to denials and spend another $20 billion trying to recover that money, yet fewer than 15% of denials are appealed even though more than half of appeals succeed. The pain is especially acute for hospitals, billing teams, and practices that must manually identify denials, gather clinical and payer documentation, draft compliant appeals, and meet submission deadlines. The central use case is recovering high-value claims that would otherwise be written off because the appeal process is too slow, costly, or complex to handle at scale.

Product / Service

Aegis is an AI-enabled denial-management and revenue-recovery platform that integrates with a provider’s existing EHR, practice-management system, and clearinghouse. It detects denied claims, ranks them by financial value, deadline, and likelihood of overturn, retrieves relevant records and explanation-of-benefits documents, generates a payer-aware appeal packet, submits it through the appropriate channel, and tracks the result. Its analytics also identify recurring denial patterns by payer, procedure, provider, and code so organizations can reduce future denials rather than only pursue past-due claims.

The delivery model is software for billing teams, hospitals, and healthcare providers, with automation designed to keep staff focused on exceptions and decisions rather than repetitive paperwork. Aegis says its platform can reduce denial-resolution time and cost substantially, reporting 90% faster resolution, 90% lower cost per denial, four times more denials resolved, a five-minute average time to resolution, and submissions to more than 20 insurers. These are company-reported partner-network metrics rather than independently verified outcomes.

Market

Aegis competes in healthcare revenue-cycle management, specifically the AI-driven claims-denial prevention, appeal, and recovery segment. The category includes established revenue-cycle vendors such as Waystar, whose platform also offers denial and appeal management, although the available evidence does not provide a definitive, exhaustive competitor list. Aegis’s differentiation is its emphasis on an end-to-end AI-agent workflow that moves from denial detection through documentation, appeal generation, submission, tracking, and revenue analytics.

The company appears to be an early-stage entrant rather than a mature revenue-cycle incumbent. Y Combinator lists Aegis as founded in 2025, part of its Spring 2025 batch, active, and headquartered in San Francisco with a three-person team; YC also published an Aegis launch page in May 2025. The company website reports meaningful operational results across a partner network, but the available research does not disclose revenue, customer count, funding amount, or enough evidence to establish scale. It is therefore best characterized as an active, early commercial-stage startup with reported product traction, not as a clearly established revenue-generating platform.